DARA......just slowly selling off because the decision on Orphan status is taking longer than many hoped......which is being interpreted as a NO is forthcoming from the FDA.
Mgt. leaves lots to be desired IMO....as the submission obviously needed clarification per their IR and I bet it had to do with the population. I wonder if Napadano and others will back track on their view of DARA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.